Back to search
Schizophrenia and Related Disorders
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Schizophrenia and Related Disorders trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Schizophrenia and Related Disorders trials you may qualify forThis study will evaluate the efficacy of valbenazine on clinician- and patient-reported outcomes in participants with TD while receiving or after stopping a VMA…
This observational study will characterise the general psychiatric and general medical phenotypes of 100 adults, sequentially admitted to NHS General Adult Psyc…
This project aims to evaluate feasibility, validity and clinically applicability to systematically measure fitness in patients with severe mental illness. The…
This is an observational study aiming to screen biomarkers associated with the diagnosis and treatment outcomes of severe mental disorders (MDD/major depressive…
The aim of the present study is to assess the availability of cannabinoid receptors (CB1R) in the human brain. CB1R are present in everyone's brain, regardless…
Schizophrenia spectrum disorders (SSDs) have a significant trauma etiology: trauma has been reported in 65 - 80% in this patient group and have a negative impac…
The combination of pharmacotherapy and individual cognitive behavioral therapy in a private practice.
The goal of this study is to reduce Anticholinergic Medication (ACM) in persons with psychoses or serious mental illness, when these medications are no longer n…